In pharmacovigilance, a safety signal is information that suggests a possible new association between a medicine and an adverse event.
But a signal is only the starting point. It needs to be assessed and investigated before conclusions can be drawn.
At PHARMYA, we support our partners in the continuous monitoring and assessment of medicine safety.
Interested in learning more about our services?
We’ll get back to you promptly

